Generic name |
icosapent ethyl |
|
---|---|---|
Strength |
1 gram |
|
Form |
capsule |
Special Authority criteria |
Approval period |
---|---|
As combination therapy with an HMG-CoA reductase inhibitor (statin) for the secondary prevention of established cardiovascular disease in patients 45 years of age and older who meet ALL of the following criteria:
|
Indefinite |